Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

acute myeloid leukemia with inv(16)(p13.1q22); cbfb-myh11, acute myeloid leukemia with t(16;16)(p13.1;q22); cbfb-myh11, acute myeloid leukemia with t(8;21); (q22; q22.1); runx1-runx1t1, de novo myelodysplastic syndrome, high risk myelodysplastic syndrome, inv(16), myelodysplastic syndrome with excess blasts, t(16;16), t(8;21), untreated adult acute myeloid leukemia, interventional, phase2